Embryo biopsy is a specialized procedure used during in vitro fertilization (IVF) to extract a few cells from an embryo for genetic testing. This testing helps identify chromosomal abnormalities or specific genetic disorders before the embryo is implanted into the uterus. The two main types of genetic testing performed after an embryo biopsy are Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD). PGS is used to screen for chromosomal abnormalities, while PGD is focused on detecting specific inherited genetic conditions.
By performing an embryo biopsy for PGS or PGD, fertility specialists can select embryos that are free of genetic disorders or chromosomal abnormalities, improving the chances of a healthy pregnancy and reducing the risk of miscarriage or genetic conditions. This technique is particularly beneficial for couples with a history of genetic diseases, recurrent miscarriages, or women of advanced maternal age.
Embryo biopsy for PGS or PGD is recommended in specific situations where genetic risks are a concern. Some common reasons for opting for these procedures include:
Before an embryo biopsy can be performed, the female partner undergoes the standard IVF process, which includes ovarian stimulation, egg retrieval, and fertilization of the eggs with sperm. Once fertilization occurs, the embryos are allowed to develop in the lab for several days, typically reaching the blastocyst stage (around day 5 or 6).
When the embryo reaches the blastocyst stage, a small biopsy is performed. Using a high-powered microscope and specialized instruments, an embryologist carefully removes a few cells from the trophectoderm (the outer layer of the embryo, which will later form the placenta). This procedure is non-invasive to the inner cells that will develop into the fetus and does not harm the embryo’s viability.
Once the cells are biopsied, they are sent to a genetic laboratory for analysis. For PGS, the lab screens the cells for chromosomal abnormalities such as aneuploidy (the presence of too few or too many chromosomes). For PGD, the cells are analyzed for specific genetic mutations or conditions based on the couple’s medical history or known genetic risks.
After the biopsy, the embryos are frozen (cryopreserved) while awaiting the results of the genetic testing. This allows for a more flexible and less time-sensitive transfer, giving the fertility specialist time to review the results and plan the transfer of the healthiest embryos in a future cycle.
Once the PGS or PGD results are available, the fertility specialist will select the healthiest, chromosomally normal embryos (in the case of PGS) or the embryos free of genetic disorders (in the case of PGD) for transfer. The embryo transfer is a simple procedure in which the selected embryo is placed into the woman’s uterus, where it can implant and grow into a healthy pregnancy.
If you are considering embryo biopsy for PGS or PGD as part of your fertility treatment, our team of experts is here to guide you through the process. We offer personalized consultations to help determine whether genetic testing is right for your situation. Call us at +91 9599754455 or fill out the contact form below to schedule an appointment and take the next step toward a healthy pregnancy.